脱氧核糖核酸酶Ⅰ(牛胰)
货号-规格 | 货期 | 价格 | 数量 |
abs47047435-100mg | 现货 | ¥578.00 | - + |
abs47047435-500mg | 1-2周 | ¥2079.00 | - + |
温馨提示:本产品仅作科研实验使用,不支持临床等研究 |
- 实验方法 实验条件
共 0 张,还能上传 8 张 提交
- 提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要咨询”按钮填写您的疑问。
提交不成功?请联系info@absin.cn。
- Near-infrared-II Ag2S quantum dot probes targeting podoplanin enhance immunotherapy in oral squamous cell carcinoma
Honggang Xiong, Shuhui Shao, Yixin Yang, Weiming Wang, Haofeng Xiong, Ying Han, Zijia Wang, Xin Hu, Liujun Zeng, Zhimin Yang, Tong Su
BIOMEDICINE & PHARMACOTHERAPY. 2023 Dec 29 .
影响因子: 7.5
- The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning-Ning Liu, Cheng-Xiang Yi, Lu-Qi Wei, Jin-An Zhou, Tong Jiang, Cong-Cong Hu, Lu Wang, Yuan-Yuan Wang, Yun Zou, Yi-Kai Zhao, Le-Le Zhang, Ya-Ting Nie, Yi-Jing Zhu, Xin-Yao Yi, Ling-Bing Zeng, Jing-Quan Li, Xiao-Tian Huang, Hong-Bin Ji, Zisis Kozlakidis, Lin Zhong, Hui Wang
Cancer Cell. 2023 Sep 21 .
影响因子: 50.3
- Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides “one-two punch” opportunity with anti-PD-L1 therapy in colorectal cancer
Tao Wang, Weizhen Liu, Qian Shen, Ruikang Tao, Chengguo Li, Qian Shen, Yao Lin, Yongzhou Huang, Lei Yang, Gengchen Xie, Jie Bai, Ruidong Li, Lulu Wang, Kaixiong Tao, Yuping Yin
Cancer Science. 2023 Sep 13 .
影响因子: 5.7
- Host-microbe interactions mediate doramectin-promoted metabolic reprogramming of CD8+ T-cells and amplify antitumor immunity
Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Wen Jiang, Vincenzo Casolaro, Luis G. Bermúdez-Humarán, Florencia McAllister, Zhongwei Lv, Dan Li
bioRxiv. 2023 Jan 31 .
- Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Yi, Ming, Niu, Mengke, Wu, Yuze, Ge, Hong, Jiao, Dechao, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Chu, Qian, Wu, Kongming
Journal of Hematology & Oncology. 2022 Oct 08 .
影响因子: 23.168
- TGF-β抑制剂增强不可逆电穿孔联合抗PD1抗体治疗胰腺癌疗效的研究
沈健
华中科技大学. 2022 May 01 .
- Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Ming Yi,Mengke Niu,Jing Zhang,Shiyu Li,Shuangli Zhu,Yongxiang Yan,Ning Li,Pengfei Zhou,Qian Chu,Kongming Wu
J Hematol Oncol.. 2021 Sep 15 .